NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026
Details
- Buyer
- NHS England
- Supplier(s)
25 suppliers
- AVENTIS PHARMA LIMITED
- Accord UK Ltd
- Amgen Ltd
- Bayer Public Limited Company
- Biogen Idec Ltd
- CHUGAI PHARMA LIMITED
- Cipla (EU) Ltd
- CST Pharma Limited
- Eli Lilly and Company Ltd
- GEDEON RICHTER (UK) LIMITED
- GLAXOSMITHKLINE UK LIMITED
- Laboratoires Juvise Pharmaceuticals
- Merck Serono Limited
- Milpharm Ltd/aurobinbdo
- Napp Pharmaceuticals Ltd
- Novo Nordisk Ltd
- ORIFARM UK LTD
- Pfizer Liimted
- Pharmacosmos UK Ltd
- Roche Products Ltd
- Sandoz
- Teva UK Ltd
- Thornton and Ross
- Viatris UK Healthcare Ltd
- Vifor Pharma UK Ltd
- Value
- GBP 201,659,945
- Duration
- 1 year
- Topic
- Pharmaceutical products
- Published
- 23 June 2026
- Source
- uk:find_a_tender
Tender description
NHS Branded Framework Agreement – Lot 1 - Tranche A for the North of England and Midlands & East. Period of Framework Agreement: 1st September 2026 to 31st August 2028 with an option or option(s) to extend (at the authority’s discretion for a further 24 months. Lot 2 - Natalizumab for London and South of England. The period of Framework Agreement: 1st September 2026 to 31st August 2027 with an option or option(s) to extend for a further 12 months. ## Contract award Title: Lot 1 - CM/PHR/25/5730/01 - NHS Branded Medicines Tranche A for Midlands & East Lots: - Lot 1: CM/PHR/25/5730/01 - Tranche B for NOFE and MAE ## Contract award Title: Lot 2 - CM/PHR/25/5730/02 - Natalizumab for London & South of England Lots: - Lot 2: CM/PHR/25/5730/02 - Natalizumab for London & SOFE
Timeline
- Completed: Award date15 June 2026
- Completed: Award published23 June 2026Current notice
- Next: Contract expiry date31 August 2027in 12 months
About the buyer
NHS England is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-england.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-england.gov |
6 similar open tenders
See more open tenders related to NHS Branded Medicines Tranche A - NOFE and Midlands & East and Natalizumab for London & SOFE - 1 September 2026.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS England.
- 455£2.1bn
- 367£249.3m
- 353£15.0bn
- 293£2.8bn
- 261£19.7bn
- 252£892.4m
- 243£509.0m
- 203£1.0bn
- 140£895.5m
- 114£59.4m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
